Interaction of oxygen-carrying resuscitation fluids with morphine

John M. Kemner, Wayne R. Snodgrass, Samuel E. Worley, Glenn R. Hodges, Gary M. Clark, Charles E. Hignite

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The oxygen-carrying resuscitation fluids, Fluosol DA 20% and stroma-free hemoglobin, are currently being evaluated for efficacy and effects in vivo. Because these fluids may be administered to trauma victims, the pharmacokinetics of morphine was studied in rats after transfusion with one of these fluids. During development of high-performance liquid chromatography assay for morphine in plasma, an in vitro interaction between plasma, Fluosol DA, or stroma-free hemoglobin and morphine was observed at pH greater than 10.5. This interaction was dependent on pH and was specific to morphine, compared with codeine. The interaction between stroma-free hemoglobin and morphine appeared to be covalent in nature. The t 1 2 of morphine was significantly prolonged from 1.02 ± 0.50 hours (mean ± SD) to 2.46 ± 2.68 hours (p = 0.03) after transfusion with stroma-free hemoglobin, and to 2.05 ± 0.95 hours (p = 0.006) after transfusion with Fluosol DA. The volume of distribution was increased from 1.35 ± 0.81 L · kg-1 to 2.99 ± 1.45 L · kg-1 (p = 0.004) after transfusion with stroma-free hemoglobin; no such difference was observed after transfusion with fluosol DA (p = 0.86). The area under the timeconcentration curve was increased from 2.37 ± 1.78 mg · hr · L-1 to 6.02 ± 6.61 mg · hr · L-1 (p = 0.02), and total body clearance was decreased from 1.02 ± 0.53 L · hr-1 · kg-1 to 0.55 ± 0.36 L · hr-1 · kg-1 (p = 0.01) after transfusion with Fluosol DA. No significant differences were observed in these parameters after transfusion with stroma-free hemoglobin (p = 0.48 and p = 0.81, respectively). These data show that stroma-free hemoglobin prolongs the t 1 2 of morphine by altering the volume of distribution. In contrast, Fluosol DA prolongs the t 1 2 of morphine by altering the total body clearance. These data may have important therapeutic implications.

Original languageEnglish (US)
Pages (from-to)433-444
Number of pages12
JournalThe Journal of Laboratory and Clinical Medicine
Volume104
Issue number3
StatePublished - 1984
Externally publishedYes

Fingerprint

Resuscitation
Morphine
Oxygen
Fluids
Plasma interactions
Codeine
Pharmacokinetics
High performance liquid chromatography
stroma free hemoglobin
Area Under Curve
glucose, glycerol, hydroxyethyl starch, perfluorodecalin, perfluorotripropylamine, pluronic F-68, salts, yolk phospholipids drug combination
Rats
Assays
High Pressure Liquid Chromatography
Plasmas

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Kemner, J. M., Snodgrass, W. R., Worley, S. E., Hodges, G. R., Clark, G. M., & Hignite, C. E. (1984). Interaction of oxygen-carrying resuscitation fluids with morphine. The Journal of Laboratory and Clinical Medicine, 104(3), 433-444.

Interaction of oxygen-carrying resuscitation fluids with morphine. / Kemner, John M.; Snodgrass, Wayne R.; Worley, Samuel E.; Hodges, Glenn R.; Clark, Gary M.; Hignite, Charles E.

In: The Journal of Laboratory and Clinical Medicine, Vol. 104, No. 3, 1984, p. 433-444.

Research output: Contribution to journalArticle

Kemner, JM, Snodgrass, WR, Worley, SE, Hodges, GR, Clark, GM & Hignite, CE 1984, 'Interaction of oxygen-carrying resuscitation fluids with morphine', The Journal of Laboratory and Clinical Medicine, vol. 104, no. 3, pp. 433-444.
Kemner JM, Snodgrass WR, Worley SE, Hodges GR, Clark GM, Hignite CE. Interaction of oxygen-carrying resuscitation fluids with morphine. The Journal of Laboratory and Clinical Medicine. 1984;104(3):433-444.
Kemner, John M. ; Snodgrass, Wayne R. ; Worley, Samuel E. ; Hodges, Glenn R. ; Clark, Gary M. ; Hignite, Charles E. / Interaction of oxygen-carrying resuscitation fluids with morphine. In: The Journal of Laboratory and Clinical Medicine. 1984 ; Vol. 104, No. 3. pp. 433-444.
@article{2b8b469dabf945409974f7f22c5d412f,
title = "Interaction of oxygen-carrying resuscitation fluids with morphine",
abstract = "The oxygen-carrying resuscitation fluids, Fluosol DA 20{\%} and stroma-free hemoglobin, are currently being evaluated for efficacy and effects in vivo. Because these fluids may be administered to trauma victims, the pharmacokinetics of morphine was studied in rats after transfusion with one of these fluids. During development of high-performance liquid chromatography assay for morphine in plasma, an in vitro interaction between plasma, Fluosol DA, or stroma-free hemoglobin and morphine was observed at pH greater than 10.5. This interaction was dependent on pH and was specific to morphine, compared with codeine. The interaction between stroma-free hemoglobin and morphine appeared to be covalent in nature. The t 1 2 of morphine was significantly prolonged from 1.02 ± 0.50 hours (mean ± SD) to 2.46 ± 2.68 hours (p = 0.03) after transfusion with stroma-free hemoglobin, and to 2.05 ± 0.95 hours (p = 0.006) after transfusion with Fluosol DA. The volume of distribution was increased from 1.35 ± 0.81 L · kg-1 to 2.99 ± 1.45 L · kg-1 (p = 0.004) after transfusion with stroma-free hemoglobin; no such difference was observed after transfusion with fluosol DA (p = 0.86). The area under the timeconcentration curve was increased from 2.37 ± 1.78 mg · hr · L-1 to 6.02 ± 6.61 mg · hr · L-1 (p = 0.02), and total body clearance was decreased from 1.02 ± 0.53 L · hr-1 · kg-1 to 0.55 ± 0.36 L · hr-1 · kg-1 (p = 0.01) after transfusion with Fluosol DA. No significant differences were observed in these parameters after transfusion with stroma-free hemoglobin (p = 0.48 and p = 0.81, respectively). These data show that stroma-free hemoglobin prolongs the t 1 2 of morphine by altering the volume of distribution. In contrast, Fluosol DA prolongs the t 1 2 of morphine by altering the total body clearance. These data may have important therapeutic implications.",
author = "Kemner, {John M.} and Snodgrass, {Wayne R.} and Worley, {Samuel E.} and Hodges, {Glenn R.} and Clark, {Gary M.} and Hignite, {Charles E.}",
year = "1984",
language = "English (US)",
volume = "104",
pages = "433--444",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Interaction of oxygen-carrying resuscitation fluids with morphine

AU - Kemner, John M.

AU - Snodgrass, Wayne R.

AU - Worley, Samuel E.

AU - Hodges, Glenn R.

AU - Clark, Gary M.

AU - Hignite, Charles E.

PY - 1984

Y1 - 1984

N2 - The oxygen-carrying resuscitation fluids, Fluosol DA 20% and stroma-free hemoglobin, are currently being evaluated for efficacy and effects in vivo. Because these fluids may be administered to trauma victims, the pharmacokinetics of morphine was studied in rats after transfusion with one of these fluids. During development of high-performance liquid chromatography assay for morphine in plasma, an in vitro interaction between plasma, Fluosol DA, or stroma-free hemoglobin and morphine was observed at pH greater than 10.5. This interaction was dependent on pH and was specific to morphine, compared with codeine. The interaction between stroma-free hemoglobin and morphine appeared to be covalent in nature. The t 1 2 of morphine was significantly prolonged from 1.02 ± 0.50 hours (mean ± SD) to 2.46 ± 2.68 hours (p = 0.03) after transfusion with stroma-free hemoglobin, and to 2.05 ± 0.95 hours (p = 0.006) after transfusion with Fluosol DA. The volume of distribution was increased from 1.35 ± 0.81 L · kg-1 to 2.99 ± 1.45 L · kg-1 (p = 0.004) after transfusion with stroma-free hemoglobin; no such difference was observed after transfusion with fluosol DA (p = 0.86). The area under the timeconcentration curve was increased from 2.37 ± 1.78 mg · hr · L-1 to 6.02 ± 6.61 mg · hr · L-1 (p = 0.02), and total body clearance was decreased from 1.02 ± 0.53 L · hr-1 · kg-1 to 0.55 ± 0.36 L · hr-1 · kg-1 (p = 0.01) after transfusion with Fluosol DA. No significant differences were observed in these parameters after transfusion with stroma-free hemoglobin (p = 0.48 and p = 0.81, respectively). These data show that stroma-free hemoglobin prolongs the t 1 2 of morphine by altering the volume of distribution. In contrast, Fluosol DA prolongs the t 1 2 of morphine by altering the total body clearance. These data may have important therapeutic implications.

AB - The oxygen-carrying resuscitation fluids, Fluosol DA 20% and stroma-free hemoglobin, are currently being evaluated for efficacy and effects in vivo. Because these fluids may be administered to trauma victims, the pharmacokinetics of morphine was studied in rats after transfusion with one of these fluids. During development of high-performance liquid chromatography assay for morphine in plasma, an in vitro interaction between plasma, Fluosol DA, or stroma-free hemoglobin and morphine was observed at pH greater than 10.5. This interaction was dependent on pH and was specific to morphine, compared with codeine. The interaction between stroma-free hemoglobin and morphine appeared to be covalent in nature. The t 1 2 of morphine was significantly prolonged from 1.02 ± 0.50 hours (mean ± SD) to 2.46 ± 2.68 hours (p = 0.03) after transfusion with stroma-free hemoglobin, and to 2.05 ± 0.95 hours (p = 0.006) after transfusion with Fluosol DA. The volume of distribution was increased from 1.35 ± 0.81 L · kg-1 to 2.99 ± 1.45 L · kg-1 (p = 0.004) after transfusion with stroma-free hemoglobin; no such difference was observed after transfusion with fluosol DA (p = 0.86). The area under the timeconcentration curve was increased from 2.37 ± 1.78 mg · hr · L-1 to 6.02 ± 6.61 mg · hr · L-1 (p = 0.02), and total body clearance was decreased from 1.02 ± 0.53 L · hr-1 · kg-1 to 0.55 ± 0.36 L · hr-1 · kg-1 (p = 0.01) after transfusion with Fluosol DA. No significant differences were observed in these parameters after transfusion with stroma-free hemoglobin (p = 0.48 and p = 0.81, respectively). These data show that stroma-free hemoglobin prolongs the t 1 2 of morphine by altering the volume of distribution. In contrast, Fluosol DA prolongs the t 1 2 of morphine by altering the total body clearance. These data may have important therapeutic implications.

UR - http://www.scopus.com/inward/record.url?scp=0021220458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021220458&partnerID=8YFLogxK

M3 - Article

C2 - 6470567

AN - SCOPUS:0021220458

VL - 104

SP - 433

EP - 444

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 3

ER -